Regeneron Pharmaceuticals
(REGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 648,719 | 535,608 | 230,276 | 483,610 | 112,572 |
| Marketable Securities | 251,761 | 158,376 | 77,819 | 43,332 | 136,796 |
| Receivables | 976,372 | 954,967 | 693,120 | 103,035 | 81,917 |
| Inventories | 128,861 | 70,354 | 28,638 | N/A | N/A |
| Income taxes - deferred | N/A | 44,677 | 148,134 | 0 | N/A |
| TOTAL | $2,084,759 | $1,796,934 | $1,206,012 | $665,777 | $357,622 |
| Non-Current Assets | |||||
| PPE Net | 974,309 | 526,983 | 379,940 | 367,955 | 347,450 |
| Investments And Advances | 460,154 | 389,891 | 271,230 | 275,887 | 370,053 |
| Other Non-Current Assets | 318,450 | 237,205 | 223,308 | 13,964 | 14,307 |
| TOTAL | $1,752,913 | $1,154,079 | $874,478 | $657,806 | $731,810 |
| Total Assets | $3,837,672 | $2,951,013 | $2,080,490 | $1,323,583 | $1,089,432 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 483,489 | 250,896 | 111,345 | 95,625 | 53,658 |
| Other current liabilities | 97,146 | 939 | N/A | N/A | N/A |
| TOTAL | $654,660 | $298,835 | $163,550 | $148,271 | $109,056 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 74,025 | 47,000 | 50,831 | 51,640 | 54,723 |
| Other Non-Current Liabilities | 186,574 | 331,645 | 303,777 | 281,462 | 7,350 |
| TOTAL | $632,761 | $700,102 | $671,555 | $689,580 | $452,561 |
| Total Liabilities | $1,287,421 | $998,937 | $835,105 | $837,851 | $561,617 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,617 | 99,928 | 97,451 | 93,889 | 89,959 |
| Common Shares | 104 | 99 | 97 | 93 | 89 |
| Retained earnings | 216,644 | -92,692 | -517,054 | -1,267,323 | -1,045,563 |
| Other shareholders' equity | 52,721 | -1,188 | -1,166 | -1,862 | -2,491 |
| TOTAL | $2,550,251 | $1,952,076 | $1,245,385 | $485,732 | $527,815 |
| Total Liabilities And Equity | $3,837,672 | $2,951,013 | $2,080,490 | $1,323,583 | $1,089,432 |